News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Quantum Motion Technologies Ltd., a privately held company in London, UK, entered into an R&D collaboration agreement with Penn.
The cell therapy startup recently raised $17 million to advance its lead immunotherapy candidates in a second pre-Series A round of funding.
U.S. Patent No. 11, 494,461 “Metastructures for solving equations with waves” was awarded and issued on Nov. 8, 2022.
oT4Ag, the NSF-funded Engineering Research Center for precision agriculture led by Penn Engineering, has successfully recruited a diverse group of 19 industry leaders and innovative start-ups.
A new Philadelphia Business Journal article explains how in addition to being a hub for cell and gene therapy, the Philadelphia area is emerging as an active player in the field of gene editing.
AlphaThera, a startup company co-founded by Andrew Tsourkas, PhD, entered into an expanded license agreement with Penn.
Penn spinout company Verismo Therapeutics has successfully raised $7 million in a pre-Series A round led by BRV Capital Management.
In CBRE’s 2023 Life Sciences Research Talent report, Philadelphia ranked sixth among the top 25 US life sciences markets, two spots above its number eight ranking from last year.
The Penn research team, led by principal investigator Dr. Rajan Jain aims to study how cardiac cells establish and maintain their identity over a lifetime.
The goal of the gift, donated by Wharton alum Marc Wolpow, is to create an incubator and accelerator for student ventures in health care.